These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8807114

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pneumocystis carinii pneumonitis following bone marrow transplantation.
    Tuan IZ, Dennison D, Weisdorf DJ.
    Bone Marrow Transplant; 1992 Sep; 10(3):267-72. PubMed ID: 1422481
    [Abstract] [Full Text] [Related]

  • 3. Dapsone for Pneumocystis carinii prophylaxis in children undergoing bone marrow transplantation.
    Maltezou HC, Petropoulos D, Choroszy M, Gardner M, Mantzouranis EC, Rolston KV, Chan KW.
    Bone Marrow Transplant; 1997 Nov; 20(10):879-81. PubMed ID: 9404930
    [Abstract] [Full Text] [Related]

  • 4. Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study.
    De Castro N, Neuville S, Sarfati C, Ribaud P, Derouin F, Gluckman E, Socié G, Molina JM.
    Bone Marrow Transplant; 2005 Nov; 36(10):879-83. PubMed ID: 16151423
    [Abstract] [Full Text] [Related]

  • 5. Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT.
    Link H, Vöhringer HF, Wingen F, Brägas B, Schwardt A, Ehninger G.
    Bone Marrow Transplant; 1993 May; 11(5):403-6. PubMed ID: 8504275
    [Abstract] [Full Text] [Related]

  • 6. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T.
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Risk factors and prevention of pneumocystis carinii pneumonia after bone marrow transplantation].
    Link H, Vöhringer HF, Wingen F, Brägas B, Schwardt A, Ehninger G.
    Med Klin (Munich); 1992 Oct; 87 Suppl 1():39-42. PubMed ID: 1461227
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation.
    Cornelissen JJ, Fibbe WE, Schattenberg AV, Petersen EJ, Willemze R, de Witte TJ, Löwenberg B, Verdonck LF, vd Biezen A, Brand R.
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S66-70. PubMed ID: 9712499
    [Abstract] [Full Text] [Related]

  • 12. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation.
    Remberger M, Ringdén O, Ljungman P, Hägglund H, Winiarski J, Lönnqvist B, Aschan J.
    Bone Marrow Transplant; 1998 Jul; 22(1):73-8. PubMed ID: 9678799
    [Abstract] [Full Text] [Related]

  • 13. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V, Castagnola E, Dallorso S, Lanino E, Calvi A, Silvestro S, Morreale G, Giacchino R, Dini G.
    Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
    [Abstract] [Full Text] [Related]

  • 14. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
    Zuffa E, Bandini G, Bonini A, Santucci MA, Martinelli G, Rosti G, Testoni N, Zaccaria A, Tura S.
    Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
    [Abstract] [Full Text] [Related]

  • 15. Pneumocystis carinii pneumonia in renal transplant recipients.
    Branten AJ, Beckers PJ, Tiggeler RG, Hoitsma AJ.
    Nephrol Dial Transplant; 1995 Mar; 10(7):1194-7. PubMed ID: 7478123
    [Abstract] [Full Text] [Related]

  • 16. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC, Rimland D.
    Pharmacotherapy; 1996 Mar; 16(6):1030-8. PubMed ID: 8947975
    [Abstract] [Full Text] [Related]

  • 17. Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
    Vasconcelles MJ, Bernardo MV, King C, Weller EA, Antin JH.
    Biol Blood Marrow Transplant; 2000 Mar; 6(1):35-43. PubMed ID: 10707997
    [Abstract] [Full Text] [Related]

  • 18. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients.
    Jantunen E, Ruutu P, Niskanen L, Volin L, Parkkali T, Koukila-Kähkölä P, Ruutu T.
    Bone Marrow Transplant; 1997 Apr; 19(8):801-8. PubMed ID: 9134172
    [Abstract] [Full Text] [Related]

  • 19. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.
    Lewis ID, DeFor T, Weisdorf DJ.
    Bone Marrow Transplant; 2000 Sep; 26(5):539-43. PubMed ID: 11019844
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.